Related references
Note: Only part of the references are listed.Pelvic lymph-node staging with18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer-the SALT trial
B. H. E. Jansen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J. Pienta et al.
JOURNAL OF UROLOGY (2021)
PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
Lars J. Petersen et al.
CANCER IMAGING (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P. Fendler et al.
JAMA ONCOLOGY (2019)
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with 68Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node Pathology
John W. Yaxley et al.
JOURNAL OF UROLOGY (2019)
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients
Kirsten M. Selnaes et al.
EUROPEAN RADIOLOGY (2018)
Diagnostic Accuracy of Ga-68-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer
Robert M. Hicks et al.
RADIOLOGY (2018)
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P. Fendler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
68Ga-PSMA-11PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study
Wolfgang Peter Fendler et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer et al.
JOURNAL OF UROLOGY (2016)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial
David M. Schuster et al.
JOURNAL OF UROLOGY (2014)
The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis
Martin H. Umbehr et al.
EUROPEAN UROLOGY (2013)
Evidence of bias and variation in diagnostic accuracy studies
AWS Rutjes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function (trifecta)
FJ Bianco et al.
UROLOGY (2005)
Share Paper
